Daiwa Securities Group Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
+5.9%
4740.0%0.00%
Q2 2023$17
-19.0%
474
-12.9%
0.00%
Q1 2023$21
-32.3%
5440.0%0.00%
Q4 2022$31
-99.8%
544
+5.8%
0.00%
Q3 2022$20,000
-13.0%
5140.0%0.00%
Q2 2022$23,000
+43.8%
514
+25.1%
0.00%
Q1 2022$16,000
-5.9%
4110.0%0.00%
Q4 2021$17,000
-15.0%
411
-15.6%
0.00%
Q3 2021$20,000
+66.7%
487
+81.7%
0.00%
Q2 2021$12,000
+9.1%
2680.0%0.00%
Q1 2021$11,0000.0%268
+5.5%
0.00%
Q4 2020$11,000
-45.0%
254
-67.0%
0.00%
Q3 2020$20,000
+42.9%
7690.0%0.00%
Q2 2020$14,0000.0%7690.0%0.00%
Q1 2020$14,000
-6.7%
769
-7.0%
0.00%
Q4 2019$15,000
+7.1%
827
-10.3%
0.00%
Q3 2019$14,000
-12.5%
9220.0%0.00%
Q2 2019$16,000
+6.7%
9220.0%0.00%
Q1 2019$15,000
+25.0%
922
+17.2%
0.00%
Q4 2018$12,000
-14.3%
7870.0%0.00%
Q3 2018$14,000
+7.7%
7870.0%0.00%
Q2 2018$13,000
-13.3%
7870.0%0.00%
Q1 2018$15,0007870.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders